Stroke results in substantial morbidity and mortality globally. Asia-Pacific countries bear a disproportionate share of the burden of stroke, a burden that will grow as their populations' life expectancies rise. Hypertension is the single most important reversible risk factor for stroke, and effective measures to reduce blood pressure contribute significantly to reducing the incidence of stroke. The Asia-Pacific Consensus Conference on Stroke Prevention in Hypertensive Patients assembled leading experts from the region to reach an actionable consensus aimed at reducing stroke-induced morbidity and mortality in Asia through the evidence-based treatment of hypertension. The discussions of the group focused on how best to improve blood pressure control, how to promote lifestyle changes at the population level, and how to reduce the clinical and health system barriers and other challenges facing developing and low-income countries. The experts concluded that physicians must place an increased priority on reducing their patients' risk of stroke and recognise that all hypertensive patients are at greater risk of having a stroke compared with nonhypertensive individuals. They advocated that physicians must educate hypertensive patients about the risk of stroke, promote lifestyle modification to all patients diagnosed with hypertension, and prescribe rigorous antihypertensive treatment to get patients to recommended blood pressure goals.
stroke will afflict more people than ever before as populations around the world grow older, making the management of risk factors to control stroke risk an increasingly urgent healthcare priority. However, stroke is not confined to the elderly. Significant numbers of people below the age of 60 suffer a stroke every year and would also benefit from preventive measures to reduce lifelong stroke risk.
In addition to the rising death toll, stroke imposes considerable financial costs, both in terms of caring for stroke victims and lost productivity due to their incapacitation (6) . Many people who survive a stroke are left permanently disabled, often suffering from weakness or paralysis, disturbed speech, incontinence, and psychological sequelae, with the burden of care after they have left hospital often falling to their families. Japan's yearly expenditure on stroke is US$158 billion, (5) and in Singapore, the average hospital stay following admission for stroke is 17 days at a mean cost of US$7547 (US$4461) per hospitalised patient (7) . In 2003, the number of days lost per 1000 in Asia was considerably higher than it was in North America and Western Europe. Annual lost days due to stroke disability averaged four per 1000 in Germany, Italy, the United Kingdom, and the United States, and three in France, Spain, and Canada. In contrast, the Philippines and Sri Lanka averaged 7 days lost per 1000 per year, Korea and Vietnam 8 days, and stroke disability resulted in 12 lost days per 1000 in China, 11 in Cambodia, and 14 in Micronesia (8) .
Hypertension and stroke
Globally, hypertension is a major known preventable cause of cardiovascular and cerebrovascular disease, and is the most important single modifiable risk factor for stroke. Between 2000 and 2005, the prevalence of adult hypertension was predicted to increase by 60%, to affect a total of 1Á56 billion people worldwide (9) .
There is abundant evidence that treatment to lower blood pressure significantly reduces patients' risk of having a stroke, and that the benefits of controlling hypertension in terms of lives saved and increased quality of life because of reduced stroke-related disability apply to a wide range of people. A joint meeting on hypertension and cerebrovascular disease held between WHO and the International Society of Hypertension (ISH) in 1993 found strong evidence supporting the value of treating hypertension to reduce the risk of stroke, and confirmed that blood pressure-lowering regimens -largely based on the use of diuretics and b-blockers -could cut stroke risk by 35-40%. At their 2002 meeting, WHO/ISH reiterated the importance of lowering blood pressure in stroke risk reduction and emphasised that the benefits extend both to men and women, across age and racial groups, and to patients at high risk of stroke whose blood pressure is normal, as well as those with hypertension. Yet, despite compelling evidence that stroke incidence could be significantly reduced through treatment to reduce blood pressure, this has proved a challenge to achieve in clinical practice, particularly in developing countries lacking the resources, public health systems, and healthcare infrastructure available to their more wealthy counterparts.
In June 2005, leading experts in hypertension, cardiology, neurology, and general practice from eight Asian countries gathered during the Asian-Pacific Congress of Hypertension in Seoul, South Korea, to debate and reach an actionable consensus aimed at reducing stroke-induced morbidity and mortality in Asia through the evidence-based treatment of hypertension. The Consensus Conference on Stroke Prevention in Hypertensive Patients (in the context of this Consensus Statement and current healthcare, 'stroke prevention' is defined as reducing the incidence of stroke or increasing years lived free from stroke) addressed the increasing magnitude of the stroke problem throughout Asia; the underlying reasons for under diagnosis and undertreatment of hypertension; current practices and patient understanding and management; and the benefits of treating hypertensive patients to reduce the risk of stroke, and the public health and economic consequences of failure to take action. The group's discussions focused, in particular, on how best to improve blood pressure control across all Asian populations and achieve lifestyle changes at the population level, and the clinical and health system barriers and other challenges facing developing and low-income countries. They then recommended the practical measures that healthcare practitioners and guardians of public health should implement to raise awareness of the seriousness of hypertension and to make progress in alleviating the burden of stroke and improving the prospects of hypertensive patients. The meeting was supported by an educational grant from Merck and Co. Inc. representing eight Asia-Pacific countries and different fields of expertise (Table 1) . Their discussions centered on three broad themes: the epidemiology of stroke; knowledge, attitudes, and perceptions towards hypertension and the risk of stroke; and reducing the risk of stroke among patients with hypertension.
Materials and methods

Meeting format
Results
Consensus statements
Having discussed the overarching themes, the participants unanimously agreed on a number of consensus points, specific action items and recommendations to improve education, and standards of practice for reducing stroke risk among hypertensive patients in Asia (Tables 2-4 ).
Epidemiology of stroke
Stroke is a major problem in Asia and raises profound public health implications that are likely to become even more serious in the future. As a consequence of stroke risk increasing with age, extended life expectancy will inevitably increase the burden of stroke in Asian countries. In Asian countries, the ratio of strokes classified as ischemic relative to other stroke types is increasing, while across Asia 
Consensus action points Recommendations
Quantify stroke risk relative to other public health threats in a way that patients, healthcare professionals, and decision makers can understand Inform governments about the burden and costs of inaction versus the rewards of implementing proven modern therapeutic interventions to protect patients from stroke
Collate national data on risk factors, incidence, and prevalence Determine the trends and the burden of hypertension and stroke, including both the direct and indirect costs associated with stroke, e.g., the burden on carers, and produce a definitive public health report Table 3 Knowledge, attitudes, and perceptions toward hypertension and the risk of stroke: consensus summary
Give patients, healthcare professionals, and decision makers the information they need, and improve communication between these parties Raise awareness of stroke risk reduction and disseminate the message that stroke is not an isolated event, but leaves a potentially devastating legacy of disability requiring ongoing care and support, which not only exacts a considerable financial cost on heathcare systems but also creates a more widespread social burden on carers, family, and others Develop national education programs to communicate the link between hypertension and stroke and the importance of stroke risk reduction in hypertensive patients The media plays a key role in educating the public about the importance of reducing stroke risk, and should be encouraged to disseminate key messages to help improve the public health Patient groups need to communicate actively with patients, physician organizations, and governments Create urgency for physicians to understand the importance of reducing the risk of stroke in hypertensive patients Work with the International Society of Hypertension, the World Hypertension League, and other regional/international organizations to develop a Pan-Asian hypertension and stroke initiative to focus on strategies for Asia to better manage hypertension to reduce stroke risk Develop various educational tools that meet the needs of physicians in different regions, tailoring them to the level of resources, facilities, and treatments available Overcome barriers to treatment adherence among hypertensive patients to reduce their risk of stroke Share best practices of successful and creative patient adherence and management systems for stroke risk-reduction with all key stakeholders Develop tools to support knowledge and sustained adherence with hypertension treatment guidelines or with established national guidelines there are regional and rural/urban differences in the impact of stroke. For example, rural populations in Taiwan suffer a higher prevalence of stroke than city-dwellers (10) . Such differences can be attributed in part to different risk factor profiles for smoking, hypertension, and diabetes and may also be influenced by people's ease of access to diagnosis and treatment. They may diminish over time as rural areas become more urbanized.
Hypertension is a major reversible risk factor in stroke. It accounts for around 40% of all strokes and is clearly associated with increased risk of all stroke subtypes. Stroke incidence has been linked to high salt intake, and reduced salt intake has been linked to lower stroke incidence.
Knowledge, attitudes, and perceptions towards hypertension and the risk of stroke: hypertension is undiagnosed in two out of three patients with the condition, and even among those who are aware of their condition, fewer than half are treated and only a small fraction reach recommended blood pressure targets. To redress this imbalance, there is a need to motivate physicians to treat patients more intensively towards target levels and to encourage patients to persist with open-ended antihypertensive therapy.
Cost is a barrier to effective hypertension management for many patients in Asian countries. In some of the more affluent Asian countries, linking reimbursement to achieving recom-mended blood pressure targets might improve hypertensionassociated outcomes. In the United Kingdom, a voluntary system of financial incentives -the Quality and Outcomes Framework of GPs' General Medical Services contract -awards points that are linked to payments to general practices, based on the numbers of patients treated to a series of targets including blood pressure and cholesterol goals (11) .
There are major gaps in the understanding of hypertension and its link to stroke between patients, physicians, and the general public. Physicians appear to underestimate what their patients know about stroke and there is a need to improve communication between physicians and patients in terms of the risk of stroke. In particular, the severe economic and social burdens of caring for disabled stroke victims are underappreciated.
Reducing the risk of stroke among patients with hypertension
Current risk assessment tools that predict the absolute risk of stroke have been developed using data derived primarily from Caucasian populations, but have not yet been tested or validated for use for Asian populations. However, there is compelling evidence that controlling hypertension reduces the risk of all types of stroke no matter what their cause and Table 4 Reducing the risk of stroke among patients with hypertension: consensus summary
Consensus action points Recommendations
Emphasise the long-term importance of measures to reduce stroke risk Governments should promote programmes for a healthy lifestyle and raise people's awareness of other modifiable risk factors for stroke such as diet-in particular excessive salt intake, obesity, smoking, and lack of physical activity Acknowledge that antihypertensive drugs are generally required for substantial and prolonged blood pressure lowering in patients with hypertension Reduce blood pressure in hypertensive patients using the most appropriate drugs/drug combinations available In countries where several treatment options are available, treat hypertension using evidence-based medicine and consider benefits beyond blood pressure control aimed at stroke risk reduction Conventional and off-patent drugs are as effective as newer antihypertensives, an important consideration in countries where cost is a potential barrier to hypertensive treatment Support further studies to confirm whether or not the benefits of ARBs seen in the LIFE study are class-wide and are applicable to the general population of hypertensive patients Motivate physicians to treat hypertension more intensively, as treatment to reduce blood pressure has a proven impact on reducing stroke risk Physician organisations should encourage physicians to treat hypertension in general, and early and aggressively Develop training programmmes for doctors and other healthcare professionals Draft realistic, evidence-based, and practical treatment guidelines and develop effective, well-tolerated treatment regimens that bridge the gap between theory and practice, reduce blood pressure to treatment target, and encourage long-term patient adherence Obtain a more detailed understanding of how stroke affects Asian populations so that appropriate treatments can be better targeted to hypertensive patients Encourage governments to implement population-based stroke riskreduction strategies Validate existing risk equations in Asian populations and if necessary develop regionally relevant risk assessment scales that will more accurately predict stroke risk in Asian patients and to identify those at increased risk of stroke Implement cardiovascular risk assessment programmes to estimate the risk of stroke Set national standards and audit the performance of intervention measures against defined clinical indices no matter how far blood pressure is lowered, as long as it is tolerated and there is no evidence of adverse effects. Even a modest reduction in blood pressure is sufficient to significantly reduce the rate of stroke in Asian patients.
There is no convincing evidence to suggest additional benefits in stroke risk reduction by abandoning conventional treatments in favor of newer drugs. However, in the Losartan Intervention for Endpoint (LIFE) study (12) , comparing the ARB losartan vs. the b-blocker atenolol for patients with LVH, there was a reduction in the risk of stroke in favor of Losartan.
Patients for whom immediate treatment is required, the highest priority is to lower blood pressure as much as possible, preferably to recommended targets, using the drugs or drug combinations best suited to a patient's circumstances and ideally also combat other stroke risk factors. However, riskreduction strategies should not ignore the importance of longterm measures such as dietary or lifestyle modifications, which may not only reduce hypertension but also other cardiovascular risk factors. Stroke also affects younger patients and the benefits of antihypertensive treatment for reducing the incidence of stroke in younger age groups should not be overlooked. The clearest path to lowering the incidence of stroke in Asia is by controlling hypertension, the most important modifiable risk factor for stroke.
Discussion
The goal of the Asia-Pacific Consensus Conference on Stroke Prevention in Hypertensive Patients was to arrive at an actionable consensus aimed at reducing stroke-induced morbidity and mortality in Asia through the evidence-based treatment of hypertension. In reaching their consensus, the participants concluded unanimously that physicians must prioritize stroke risk-reduction by accepting that all hypertensive patients are at increased risk of stroke, by recommending lifestyle modification for all patients with hypertension, by using antihypertensive agents to treat hypertension to blood pressure goals, and by educating patients about stroke as the most severe consequence of hypertension in order to motivate people at risk to seek appropriate treatment. Their key recommendations for achieving these goals were to: create an urgency for physicians to understand the importance of stroke risk reduction in hypertensive patients; motivate physicians to treat hypertension more aggressively to reduce the risk of stroke; raise awareness about the potentially devastating effects of stroke and the importance of measures to reduce stroke risk;
improve patient adherence to antihypertensive treatment to reduce the risk of stroke; and educate the public on the burden and costs of inaction vs. adopting healthy lifestyle modifications and implementing proven modern therapeutic interventions to reduce lifelong stroke risk.
The primary goal of treating hypertensive patients is to reduce cardiovascular morbidity and mortality (13) , which requires the management of all reversible risk factors. It is important not to lose sight of the fact that hypertension and other cardiovascular risk factors affect not only the heart but also pose other threats. Among patients enrolled in hypertension trials, stroke occurs more frequently than myocardial infarction (14) . Although hypertension is the most common modifiable stroke risk factor, there is evidence that the absolute risk of stroke among patients with hypertension may not be fully appreciated.
In the Asia-Pacific region, greatly increased stroke or cerebrovascular risk due to hypertension is a serious and growing problem with devastating consequences for victims and their families as well as profound public health implications. As home to the majority of the world's population, and with increased life expectancy for each generation, Asia will bear the greatest global burden of stroke in the years and decades to come. There is considerable scope for improving the awareness, treatment, and control of hypertension (15, 16) , and an urgent need to improve the management of risk and to reduce stroke-related deaths and disability.
Evidence from Asian countries where stroke has been studied in some detail notably China, where hypertension accounts for as much as half of total stroke mortality (17) in Taiwan and Japan, suggests that hypertension may be more closely associated with strokes, especially haemorrhagic stroke, and accounts for the relatively greater incidence of stroke in Asian populations than Caucasian populations (18, 19) . One recent analysis estimated that a 10 mmHg increase in systolic blood pressure increased risk of haemorrhagic stroke by 72% in Asians compared with 49% in Australians and New Zealanders, suggesting that blood pressure reduction in Asian populations should be a particularly effective means of reducing stroke risk (20) . Others have estimated that lowering diastolic blood pressure by 3 mmHg in populations throughout the Asia-Pacific region could decrease the incidence of strokes by about one-third, (18) and that half or more of strokes in Asians could be avoided if hypertension was controlled to o140/90 mmHg (19) .
Data on perception gaps reveal that both patients and physicians have a role to play in reducing the incidence of strokes. First, there is a need to encourage physicians in Asia to treat hypertension and, where resources are available, to treat it more intensively, using evidence-based medicine and considering benefits beyond blood pressure control aimed at stroke risk-reduction. Stroke risk assessment is not always a routine part of practice for physicians and risk-reduction should be a higher priority when physicians treat hypertension. Both in the West and in Asia, trends in medical practice towards a greater reliance on preventive medicine and individualized treatment occasion a need for better stratification of patients using regionally relevant risk assessment protocols, to gauge patients' level of risk and identify those requiring more intensive treatment.
Guidelines developed for Caucasian patients should be evaluated for their suitability in the Asian context, and if necessary adapted to take into account the characteristics of Asian populations. Treating more patients to target will require global risk assessment to identify all at-risk or potentially atrisk individuals in the population. Such assessments should take into account all the relevant risk factors: smoking, hyperlipidemia, diabetes, impaired glucose tolerance, metabolic syndrome, family or prior history of coronary vascular disease (CVD), for example peripheral arterial disease, coronary artery disease, or cardiovascular events. It will also be important to take steps to improve the identification of target organ damage (due to CVD risks such as hypertension, diabetes, and atherosclerosis). Incentives to physicians such as performance audits linked to reimbursement or bonuses may be a useful means to accomplish improved vigilance and encourage early intervention. A regional community hypertension screening and intervention trial that ran for 3Á5 years in seven cities in China and a similar scheme in rural Japan both achieved substantial reductions in the incidence of hypertension (21, 22) .
Although patients and the public seem to appreciate the link between hypertension and stroke, they underestimate the seriousness of hypertension and the impact of stroke. This may be because of a lack of appreciation that hypertension can be controlled or that such a serious condition could be asymptomatic, limited awareness that controlling blood pressure reduces the likelihood of stroke, and/or a lack of knowledge about the debilitating consequences of stroke. At present, there is a discrepancy between what physicians believe their patients know and what patients actually understand, suggesting a communication breakdown at the patient-physician interface. Patient consultations offer a golden opportunity for initiating communication between doctors and patients to improve patient appreciation of the importance of hypertension, and the role of treatment in reducing the risk of stroke.
Public-directed initiatives will be required to raise awareness of the dangers of hypertension, while guidelines for physicians should take into account the probable need for combination therapy, patients' concerns about taking antihypertensive medications, and the need for better risk assessment to identify patients who will benefit from more aggressive treatment. Recognition and acknowledgment of patients' perspectives will be particularly important in determining the success of such measures. In a recent survey, more than 80% of patients said that given the choice, they would prefer to lower their blood pressure without taking medication and questioned the need for continuing medication. Most reported experiencing unwelcome side effects from antihypertensive medication and many cited concerns about possible adverse long-term consequences of anti hypertensive therapy (23) , suggesting that efforts should be directed at developing and optimizing patient-friendly treatment regimens.
Insight as well as information will be crucial to facilitating productive dialogue about stroke, and all parties concerned should have access to the information they need to educate themselves about the perceptions and needs of others. Patient and public education through other communication channels encompassing printed and electronic media should also be investigated. One such study in Japan, which evaluated the impact of a regular patient newsletter to convey messages emphasizing the importance of persistence with drug therapy and adopting healthy lifestyle changes, found that despite positive feedback from patients, it had no apparent effect on adherence (24) , highlighting the importance of rigorous piloting and evaluation to develop effective communication strategies.
It is incumbent on healthcare agencies in the region to review local best practices to achieve better stroke risk management in hypertensive patients. Better-targeted treatment will help both to extract maximum value from the healthcare resources available and help to improve patient adherence. Already, Korean researchers have conducted a national prospective occupational cohort survey of hypertension and stroke (25) , while the Ministry of Health in Malaysia has instituted national initiatives including surveys of prevalence and treatment success to reduce stroke risk in hypertensive patients (26) , allied to public educational programs and healthy lifestyle campaigns. In parallel, the National Heart Association of Malaysia has worked with the Ministry of Health, the Academy of Medicine of Malaysia, and other learned societies, to produce physician-driven clinical practice guidelines on hypertension, stroke, and related cardiovascular disorders. The guidelines are reinforced by continuing medical education to regularly highlight and share advances in treatment to target, by encouraging cooperation in GP-based research on treatment or audits of management outcome, and by quality assessment and adherence audits monitoring different clinical indexes.
Three-quarters of hypertensive patients are already receiving two or more antihypertensive medications, and as the shift away from conventional monotherapies towards combination therapy continues, it will become increasingly important to take into account factors including: safety; patient acceptance; cost; dosing regimens; the need for laboratory follow-up; mechanism of action and potential interaction with other drugs; treatment of associated risk factors with adjunct therapies; and additional salutary effects (27) . However, the vital importance of persuading people to adopt healthy lifestyle changes cannot be underestimated. This is already a high priority on the political agenda in European countries, for example the United Kingdom, where it is the cornerstone of the public health strategy set out in the Government's 2004 White Paper Choosing Health: Making Healthy Choices Easier (28) . While research into the aetiology of hypertension in Asia-Pacific indicates that its causes are generally similar to Western populations, obesity, and certain dietary constituents other than salt may be implicated to a greater extent than in Caucasians (29) . In the Asia-Pacific region, healthier lifestyle initiatives at national or regional levels should draw on research into whether Western guidelines for controlling preventable risk factors such as quitting smoking, eating a high-fiber, low-fat diet, reducing salt intake, taking regular physical exercise, and moderating alcohol consumption can also be applied in Asia-Pacific populations.
